期刊文献+

鼻咽癌调强放疗后感音神经性听力下降的临床分析 被引量:4

Clinical analysis of risk factors for sensorineural hearing loss in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
原文传递
导出
摘要 目的 分析鼻咽癌患者调强放疗后感音神经性听力下降(SNHL)的影响因素.方法 比较2012-2013年间接受单纯放疗和同期放化疗的29例鼻咽癌患者声导抗测听、纯音听阈测定及耳蜗放射剂量,所有患者均接受调强放疗.采用前瞻性分析方法分析耳蜗放射剂量对鼻咽癌患者SNHL的影响,同时了解放疗后时间、化疗、T分期、年龄等因素对结果的影响.结果 58只耳中6只(10%)发生了低频SNHL,17只(29%)发生高频SNHL.放疗后发生感音神经性耳聋患者和未发生听力下降患者耳蜗剂量不同(左耳46.1 Gy∶35.5 Gy,P=0.006;右耳45.0 Gy∶35.8 Gy,P=0.009).当耳蜗平均剂量限制到44 Gy以下时只有15% (6/38)耳发生SNHL.颅底骨质破坏对听力有影响(P =0.047).结论 耳蜗的平均剂量和颅底骨质的侵犯是鼻咽癌患者放疗后SNHL的重要影响因素.建议耳蜗的平均剂量限制在44 Gy是合理的. Objective To investigate the risk factors for sensorineural hearing loss (SNHL) in patients with nasopharyngeal carcinoma (NPC) after intensity-modulated radiotherapy (IMRT).Methods From January 2012 to January 2013,29 patients with histopathologically confirmed NPC who received radiotherapy alone or concurrent chemoradiotherapy were included in this study.All patients underwent hearing tests,including pure tone audiometry and acoustic immittance measurement,before and after the IMRT.The cochlear doses for each ear were also collected for analysis.A prospective analysis was performed to investigate the relationship between cochlear dose and SNHL in patients with NPC,and the effects of other factors,including time after radiotherapy,chemotherapy,T stage,and age,were also analyzed.Results Of the 58 ears studied,6(10%) had low-frequency SNHL,and 17 (29%) had highfrequency SNHL.There were significant differences in mean cochlear doses between the patients who developed SNHL after radiotherapy and those who did not (left ears:46.1 Gy vs.35.5 Gy,P =0.006;right ears:45.0 Gy vs.35.8 Gy,P =0.009).When the mean cochlear dose was less than 44 Gy,only 15% (6/38) of ears had high-frequency SNHL.The invasion of skull base bone was also a significant risk factor for SNHL(P =0.047),but age,chemotherapy,and time after IMRT were not significant risk factors.Conclusions The mean cochlear dose and invasion of skull base bone are significant risk factors for SNHL in patients with NPC after radiotherapy.It is recommended that the mean cochlear dose should be limited to 44 Gy to minimize the incidence of SNHL after IMRT.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2013年第6期465-468,共4页 Chinese Journal of Radiation Oncology
关键词 鼻咽肿瘤 调强放射疗法 感音神经性听力下降 纯音听阈测定 声导抗测听 Keywords:Nasopharyngeal neoplasms/intensity-modulated radiotherapy Sensori-neural hearing loss Pure tone audiometry Acoustic immittance
  • 相关文献

参考文献15

  • 1陆雪官,刘志勇,张力元,田野.鼻咽癌放射治疗后感音神经性耳聋的临床分析[J].中华放射医学与防护杂志,2005,25(3):264-266. 被引量:10
  • 2Lee AW,Lau WH,Tung SY,et al.Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma:NPC-9901 trial by the Hong Kong nasopharyngeal cancer study group.J Clin Oncol,2005,23:6966-6975.
  • 3Wee J,Tan EH,Tai BC,et al.Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage Ⅲ and Ⅳ nasopharyngeal cancer of the endemic variety.J Clin Oncol,2005,23:6730-6738.
  • 4Al-Sarraf M,LeBlanc M,Giri PG,et al.Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer:phase Ⅲ randomized Intergroup study 0099.J Clin Oncol,1998,16:1310-1317.
  • 5Chan AT,Leung SF,Ngan RK,et al.Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.J Natl Cancer Inst,2005,97:536-539.
  • 6Chen QY,Wen YF,Guo L,et al.Concurrent chemoradiotherapy vs radiotherapy alone in stage Ⅱ nasopharyngeal carcinoma:phase Ⅲ randomized trial.J Natl Cancer Inst,2011,103:1761-1770.
  • 7Hoistad DL,Ondrey FG,Mutlu C,et al.Histopathology of human temporal bone after cis-platinum,radiation,or both.Otolaryngol Head Neck Surg,1998,118:825-832.
  • 8杜莎莎,任陈,田允鸿,谢国柱,刘英,孙权权,袁亚维.鼻咽癌根治性调强放疗后晚期耳损伤的临床研究[J].实用医学杂志,2011,27(20):3734-3736. 被引量:10
  • 9Bhandare N,Jackson A,Eisbruch A,et al.Radiation therapy and hearing loss.Int J Radiat Oncol Biol Phys,2010,76:50-57.
  • 10Chan SH,NG WT,Kam KL,et al.Sensorineural hearing loss after treatment of nasopharyngeal carcinoma:a longitudinal analysis.Int J Radiat Oncol Biol Phys,2009,73:1335-1342.

二级参考文献18

  • 1Jereczek-Fossa B A,Morra A,DeBraud F,et al.Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer.An analysis of 43 consecutive patients[J].Strahlenther Onkol,2004,180(7):425-433.
  • 2Cacciatore F,Napoli C,Abete P,et al.Quality of life determinants and hearing function in an elderly population:Osservatorio Geriatrico Campano Study Group[J].Gerontology,1999,45(6):323-328.
  • 3Herrmann F,Dorr W,Muller R,et al.A prospective study on radiation-induced changes in hearing function[J].Int J Radiat Oncol Biol Phys,2006,65(5):1338-1344.
  • 4Martin G K,Stagner B B,Lonsbury-Martin B L.Assessment of cochlear function in mice:distortion-product otoacoustic emissions[J].Curr Protoc Neurosci,2006,8:8-21.
  • 5Hamed S A,El-Attar A M.Cochlear dysfunction in hyperuricemia:otoacoustic emission analysis[J].Am J Otolaryngol,2010,31(3):154-161.
  • 6Winther F O.X-ray irradiation of the inner ear of the guinea pig.An electron microscopic study of the degenerating vestibular sensory cell[J].Acta Otolaryngol,1970,69(5):307-319.
  • 7Honore H B,Bentzen H B,Moller K,et al.Sensory neural hearing loss after radiotherapy for nasopharyngeal carcinoma; individualized risk estimation[J].Radiother Oncol,2002,65 (1):9-16.
  • 8Charlotte L Z,Yvonne J S,Emmy A L,et al.Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and neck tumors[J].Int.J.Radiation Oncology Biol Phys,2009,74(2):490-496.
  • 9Lee A W,Ng W T,Hung W M,et al.Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient-and treatment-related risk factors[J].Int J Radiat Oncol Biol Phys,2009,73(4):1121-1128.
  • 10Bhandare N,Antonelli P J,Morris C G,et al.Ototoxicity after radiotherapy for head and neck tumors[J].Int J Radiat Oncol Biol Phys,2007,67(2):469-479.

共引文献18

同被引文献43

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部